Rate My Professor Muhammad Shahzad Shabir

In November 2024, Shabir published a key study as first author in Cureus titled 'Suboptimal Vaccination Coverage and Serological Screening in Western Australian Children With Inflammatory Bowel Disease Receiving Immunosuppressive Therapy: An Opportunity for Improvement.' This audit at Perth Children's Hospital examined 243 children aged 0-18 years with IBD, of whom 52% had Crohn's disease and 43% ulcerative colitis; 74.5% were on immunomodulators and 26% on biologics. Routine childhood vaccination coverage was incomplete in 29.2% of patients, with specific deficiencies in human papillomavirus vaccine (24%), varicella (16%), and diphtheria-tetanus-pertussis (6.5%). Additional vaccines showed influenza coverage at 80% but only 1.6% for 23-valent pneumococcal vaccine. Pre-treatment serological screening compliance was low, ranging from 13.2% for Epstein-Barr virus to 74.6% for varicella. Shabir contributed to the study's concept and design, data acquisition, analysis and interpretation, manuscript drafting, and critical review. He has also co-authored research on the impact of pneumococcal vaccination on disease activity in children and adolescents with IBD over a two-year prospective study period. These contributions underscore opportunities for targeted interventions to enhance vaccination and screening practices in immunosuppressed pediatric IBD patients.